Regulates cardiac development and controls cardiac hypertrophy |
Long non-coding RNAs MEG3 and miR-361-5p |
Hypertrophic signaling and MEF2 |
[24, 46] |
Negatively regulates muscle differentiation |
MEF2 |
MEF2 |
[25] |
Connects neuronal activity to gene expression in muscle tissue |
|
AChR, MEF2 |
[48] |
Maintains the neuronal-based functions of the brain and prevents neuronal death |
|
AES |
[22, 49, 50] |
Regulates development of the limb bud |
|
Gli1and Shh signaling |
[51] |
Controls chondrocyte viability and hypertrophic maturation |
|
Nkx3.2, and the PIASy-RNF4 axis |
[52] |
Suppresses osteoclast differentiation, promotes osteogenesis, and inhibits adipogenesis of BMSCs |
miR-188 |
PPARγ/RANKL signaling, PPARγ-2, and FABP4 |
[27, 53–55] |
Regulates adipogenic differentiation |
|
C/EBPα abd adiponectin |
[56–58] |
Regulates gluconeogenesis |
|
FOXO1 |
[59–61] |
Regulates macrophage polarization |
|
ABCA1, ABCG1, and PPARγ |
[62] |
Activates antiviral innate immunity |
Dnmt3a |
TBK1-IRF3 signaling and type I IFNs |
[63] |
Regulates effector T cell-mediated systemic autoimmunity |
|
PPARγ |
[64] |
Controls regulatory T cell function |
|
Foxp3 and STAT5 |
[65–67] |
Regulates DC differentiation |
|
GATA3 |
[68] |
Promotes angiogenesis |
|
miR-17-92 cluster |
[69, 70] |